U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07916389) titled 'Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric Glioma' on Oct. 13.
Brief Summary: The purpose of this study is to test whether giving treatment before surgery helps babies who are newly diagnosed with Infant-Type Hemispheric Glioma (IHG) have safer and better surgery results.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Infant-Type Hemispheric Glioma
Intervention:
DRUG: Alectinib
By mouth, nasogastric, or gastronomy/stomach tube, Day 1-28
DRUG: Entrectinib
By mouth, nasogastric, or gastronomy/stomach tube, Day 1-28
PROCEDURE: Surgery
Primary surgery (Strata A, B, and C) post ...